AVMA news
Covetrus to pay $23M in fines for misbranded drugs
Covetrus’ North American subsidiary pleaded guilty in federal court on February 12 to introducing and delivering misbranded veterinary prescription…
AVMA news
Home delivery, autoship important offerings for veterinary clients
A recent survey from Brakke Consulting looked at consumer preferences and behaviors in pet medicine purchasing, customer satisfaction with different…
AVMA news
USP revised compounding standards go into effect
Revised compounding standards from the United States Pharmacopeia (USP) became effective November 1 after 12 years of work. According to the USP, the…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
North Carolina law will require veterinarians to report gabapentin use
As part of Governor Roy Cooper’s North Carolina Opioid Action Plan, a new law will require the state’s veterinarians to report the use of gabapentin…
AVMA news
FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat Giardia duodenalis in dogs.
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
11 technologies veterinary practices can adopt today
New devices and software promise to help enhance patient care and monitoring, ease workloads, improve workflows, meet or exceed client expectations,…
AVMA news
Midwest Veterinary Supply sentenced to one year probation, pays $11M for misbranded drugs
Minnesota-based drug company Midwest Veterinary Supply recently was sentenced to one year of probation and agreed to pay more than $11 million in…
blog
Advocacy update: Illicit xylazine, retirement saving, and budget wins
What's happening in Washington, D.C., that affects you? The AVMA's Capitol Hill update outlines some of the most recent developments.
AVMA news
Generic drugs for treating inflammation, vomiting, parasites receive FDA approval
The Food and Drug Administration announced in March and April that it had approved six generic animal drugs.
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
FDA approves first injectable pentosan for osteoarthritis in horses
The Food and Drug Administration announced Dec. 20 that the agency has approved Zycosan, the first injectable pentosan product to receive FDA…
AVMA news
FDA approves oral treatment for cats with diabetes
The Food and Drug Administration announced Dec. 8 that the agency has approved the first oral animal drug to improve glycemic control in otherwise…
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
blog
Medically important antibiotics to move from OTC to Rx
By June 2023, all medically important antibiotics will require veterinary oversight to be used in animals, even if the animals are not intended for…
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
JAVMA news
HOD passes resolution on workforce issues
AVMA leaders resolved to help address economic, staffing, and morale challenges in the veterinary workforce and they adjusted a series of existing…
JAVMA news
AVMA lobbies Congress, virtually
The AVMA hosted its annual legislative fly-in April 21, bringing veterinary students and veterinarians together virtually with their members of…
blog
Kudos! Veterinary researchers chosen to receive grants
Three veterinary researchers have been named recipients of research grants awarded by the American Veterinary Medical Foundation in partnership with…
JAVMA news
Company sold prescription drugs to unauthorized users, resellers
A drug distribution company pleaded guilty in February to selling farm-use prescription drugs to people who lacked prescriptions and resellers who…